Prophylactic lignocaine after myocardial infarction

The distribution of antibodies to streptokinase.

Postgraduate medical journal·1996

Overt and subclinical reactions to streptokinase in acute myocardial infarction.

The American journal of cardiology·1994

The significance of anti-streptokinase antibodies.

Clinical and experimental immunology·1994

Acute myocardial infarction in diabetic patients in the thrombolytic era.

Diabetic medicine : a journal of the British Diabetic Association·1994

Why do patients develop reactions to streptokinase?

Clinical and experimental immunology·1993

Fatal myocardial infarction in hypertrophic cardiomyopathy associated with non-penetrating chest trauma.

International journal of cardiology·1991

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

A Rare Presentation of Acute Cholecystitis Mimicking Malignancy in a Young Male With Elevated IgG4.

Cureus·2026

Identification of Leishmania major and Other Causative Species in Syrian Patients Infected with Cutaneous Leishmaniasis.

Iranian journal of parasitology·2026

A map of intra- and intercellular immune responses across diverse in vitro stimuli and inflammatory disease.

Genome medicine·2026

Photonic waveguide chip-based nanoscopy visualizes rearrangements of the cortical actin cytoskeleton in activated Jurkat T cells.

Science advances·2026

Protocol for deep phenotyping of human antigen-specific T cells across conventional and unconventional subsets by 22-color spectral flow cytometry.

STAR protocols·2026

Rapid and accessible tumor necrosis factor alpha detection using digital nanoparticle sensors towards point-of-care cytokine monitoring.

Sensors and actuators. B, Chemical·2026

Related Experiment Videos

Prophylactic lignocaine after myocardial infarction

Related Concept Videos

The distribution of antibodies to streptokinase.

Overt and subclinical reactions to streptokinase in acute myocardial infarction.

The significance of anti-streptokinase antibodies.

Acute myocardial infarction in diabetic patients in the thrombolytic era.

Why do patients develop reactions to streptokinase?

Fatal myocardial infarction in hypertrophic cardiomyopathy associated with non-penetrating chest trauma.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

A Rare Presentation of Acute Cholecystitis Mimicking Malignancy in a Young Male With Elevated IgG4.

Identification of Leishmania major and Other Causative Species in Syrian Patients Infected with Cutaneous Leishmaniasis.

A map of intra- and intercellular immune responses across diverse in vitro stimuli and inflammatory disease.

Photonic waveguide chip-based nanoscopy visualizes rearrangements of the cortical actin cytoskeleton in activated Jurkat T cells.

Protocol for deep phenotyping of human antigen-specific T cells across conventional and unconventional subsets by 22-color spectral flow cytometry.

Rapid and accessible tumor necrosis factor alpha detection using digital nanoparticle sensors towards point-of-care cytokine monitoring.

Related Experiment Videos

Prophylactic lignocaine after myocardial infarction

Related Concept Videos

Related Articles